Yue Alexander Wu - Net Worth and Insider Trading

Yue Alexander Wu Net Worth

The estimated net worth of Yue Alexander Wu is at least $80 dollars as of 2024-04-26. Yue Alexander Wu is the Director of Sorrento Therapeutics Inc and owns about 5,000 shares of Sorrento Therapeutics Inc (SRNE) stock worth over $80. Details can be seen in Yue Alexander Wu's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Yue Alexander Wu has not made any transactions after 2017-02-03 and currently still holds the listed stock(s).

Transaction Summary of Yue Alexander Wu

To

Yue Alexander Wu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Yue Alexander Wu owns 3 companies in total, including CASI Pharmaceuticals Inc (CASI) , Sorrento Therapeutics Inc (SRNE) , and Scilex Holding Co (SCLX) .

Click here to see the complete history of Yue Alexander Wu’s form 4 insider trades.

Insider Ownership Summary of Yue Alexander Wu

Ticker Comapny Transaction Date Type of Owner
CASI CASI Pharmaceuticals Inc 2020-06-16 director
SRNE Sorrento Therapeutics Inc 2018-11-26 director
SCLX Scilex Holding Co 2023-09-22 director

Yue Alexander Wu Latest Holdings Summary

Yue Alexander Wu currently owns a total of 1 stock. Yue Alexander Wu owns 5,000 shares of Sorrento Therapeutics Inc (SRNE) as of February 3, 2017, with a value of $80.

Latest Holdings of Yue Alexander Wu

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SRNE Sorrento Therapeutics Inc 2017-02-03 5,000 0.02 80

Holding Weightings of Yue Alexander Wu


Yue Alexander Wu Form 4 Trading Tracker

According to the SEC Form 4 filings, Yue Alexander Wu has made a total of 0 transactions in Sorrento Therapeutics Inc (SRNE) over the past 5 years. The most-recent trade in Sorrento Therapeutics Inc is the acquisition of 5,000 shares on February 3, 2017, which cost Yue Alexander Wu around $25,750.

Insider Trading History of Yue Alexander Wu

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Yue Alexander Wu Trading Performance

GuruFocus tracks the stock performance after each of Yue Alexander Wu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yue Alexander Wu is -62.75%. GuruFocus also compares Yue Alexander Wu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yue Alexander Wu within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Yue Alexander Wu's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Yue Alexander Wu

Average Return

50%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.96 -62.75 -66.67 50 -36.37 -10.14
Relative Return to S&P 500(%) -5.69 -66.7 -74.28 29.77 -44.93 -22.38

Yue Alexander Wu Ownership Network

Ownership Network List of Yue Alexander Wu

No Data

Ownership Network Relation of Yue Alexander Wu


Yue Alexander Wu Owned Company Details

What does CASI Pharmaceuticals Inc do?

Who are the key executives at CASI Pharmaceuticals Inc?

Yue Alexander Wu is the director of CASI Pharmaceuticals Inc. Other key executives at CASI Pharmaceuticals Inc include director & 10 percent owner & Chairman and CEO Wei-wu He , Chief Financial Officer Weihao Xu , and President Larry Zhang .

CASI Pharmaceuticals Inc (CASI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CASI Pharmaceuticals Inc (CASI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CASI Pharmaceuticals Inc (CASI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CASI Pharmaceuticals Inc (CASI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CASI Pharmaceuticals Inc Insider Transactions

No Available Data

Yue Alexander Wu Mailing Address

Above is the net worth, insider trading, and ownership report for Yue Alexander Wu. You might contact Yue Alexander Wu via mailing address: C/o Sorrento Therapeutics, Inc., 9380 Judicial Drive, San Diego Ca 92121.

Discussions on Yue Alexander Wu

No discussions yet.